Aveanna (AVAH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Here is how Aveanna Healthcare (AVAH) and Equillium, Inc. (EQ) have performed compared to their sector so far this year.
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q4 2024 Earnings Conference Call March 13, 2025 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer and Principal Financial Officer Conference Call Participants Megan Holt - Jefferies Michael Murray - RBC Capital Markets Benjamin Rossi - JPMorgan Chase & Company Scott Fidel - Stephen Kieran Ryan - Deutsche Bank Operator Good morning, and welcome to Aveanna Healthcare Holdings Fourth Quarter 2024 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A.
Aveanna Healthcare Holdings Inc. AVAH reported on Thursday fourth-quarter adjusted EPS of five cents, a turnaround from a loss of two cents.
While the top- and bottom-line numbers for Aveanna (AVAH) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
GILD, OPCH and AVAH demonstrate resilience with impressive earnings surprise history.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Aveanna (AVAH) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Aveanna (AVAH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Grayson McAlister - Truist Securities Operator Good morning, and welcome to the Aveanna Healthcare Holdings Third Quarter 2024 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A.
Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.03 per share a year ago.
KGC, ORLA, CVNA, CAVA and AVAH have been added to the Zacks Rank #1 (Strong Buy) List on October 25, 2024.